OncLive® On Air

Hodgkin's Lymphoma

Chemotherapy

Oncology

Colorectal Cancer

Nivolumab

Onc201

Hepatic Artery Infusion

H3K27M Mutant Diffuse Midline Gliomas

Immunotherapy

CAR T-Cell Therapy

ACTION Trial

Her2-Positive Breast Cancer

Ponatinib

FDA Approval

Swog 1826

Siltocaptagine Autolucel

Multiple Myeloma

Colorectal Cancer Management

Malignant Perivascular Epithelioid Cell Tumors

Glioma

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

31 ratings

Publishes	Daily	Episodes	500	Founded	8 years ago
Number of Listeners		Categories	ScienceHealth & Fitness

Listen to this Podcast

Guests Host Reviews Talking Points

Latest Episodes

S16 Ep40: FDA Approval Insights: Zongertinib for HER2 TKD–Mutated NSCLC: With Julia Rotow, MD; and Martin Dietrich, MD, PhD

In today’s episode, we spoke with Julia Rotow, MD, and Martin Dietrich, MD, PhD. Dr Rotow is the clinical director of the Lowe Center for Thoracic Oncology and director of clinical research at Dana-Farber Cancer Institute, as well as an assistant pro... more

Yesterday • 16 min

S16 Ep39: Community Practice Perspectives: Overcoming Barriers in Small Cell Lung Cancer Care: With Misty D. Shields, MD, PhD

In today’s episode, we spoke with Misty D. Shields, MD, PhD, about the realities of treating patients with small cell lung cancer (SCLC) in the community setting and how emerging therapies are shaping care delivery. Dr Shields is a translational medi... more

Yesterday • 15 min

S16 Ep38: Live Tumor Board: Precision Pathways Transforming Patient Care in Advanced NSCLC

In this podcast, experts Narjust Florez, MD, FASCO; David Carbone, MD, PhD; and Edward Garon, MD, MS; discuss the use of KRAS-, NRG1-, MET-, and ROS1-targeting agents to transform patient care in advanced non–small cell lung cancer (NSCLC).

27 Mar 2026 • 30 min

S16 Ep36: New Trials and Targeted Approaches Advance the Precision of GI Cancer Care: With John Marshall, MD; and Christopher Lieu, MD

In today’s episode, we sat down with John Marshall, MD, and Christopher Lieu, MD, to discuss the clinical relevance of KRAS G12C and pan-RAS inhibitors in the management of pancreatic and colorectal cancers. Dr Marshall is chief of Hematology and Onc... more

27 Mar 2026 • 18 min

Key Facts

Accepts Guests

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Oncology Brothers: Practice-Changing Cancer DiscussionsOncology Brothers

Oncology Today with Dr Neil LoveDr. Neil Love

Two Onc DocsSam and Karine

Research To Practice | Oncology VideosDr Neil Love

ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Recent Guests

John Marshall

Oncologist featured in exclusive interview

Episode: S16 Ep36: New Trials and Targeted Approaches Advance the Precision of GI Cancer Care: With John Marshall, MD; and Christopher Lieu, MD

Christopher Lieu

Oncologist featured in exclusive interview

Episode: S16 Ep36: New Trials and Targeted Approaches Advance the Precision of GI Cancer Care: With John Marshall, MD; and Christopher Lieu, MD

Kelly McCann

Breast medical oncologist at UCLA

UCLA

Episode: S16 Ep35: T-DXd Trials Transform Treatment for HER2-Positive Breast Cancer: With Sara Nunnery, MD, MSCI; and Kelly E. McCann, MD, PhD

Jae Park, MD

Physician (MD) discussing CAR T-cell therapy in ALL

Episode: S16 Ep34: Utilizing Real-World Analyses Help Make Sense of Multiple Approved CAR T-Cell Therapies for ALL: With Jae Park, MD

Marina Baretti

MD, oncologist discussed CT DNA in cholangiocarcinoma

Episode: S16 Ep33: Real-World Data Support ctDNA-Guided Treatment Strategies in FGFR2-Altered Cholangiocarcinoma: With Marina Baretti, MD

Neeta Somaiah

Professor and Chair of the Sarcoma Medical Oncology Group

MD Anderson Cancer Center

Episode: S16 Ep31: ctDNA Testing At Progression May Help Detect Resistance and Guide Sequencing in GIST: With Drs Jonathan Trent, MD, PhD, and Neeta Somaiah, MD

Wendy Stock, MD

MD, Anjuli Seth Nayak Professor of Medicine and Co-leader of the Clinical and External Therapeutics Research Program

University of Chicago Medicine

Episode: S16 Ep30: ASH Guidelines Provide Key Recommendations for AYA Acute Lymphoblastic Leukemia Management: With Wendy Stock, MD

Colin Vale

Assistant Professor in the Department of Hematology and Medical Oncology at the Emory University School of Medicine

Emory University School of Medicine

Episode: S16 Ep29: Novel Treatment Combinations for B-ALL May Help Patients Safely Achieve Remission: With Colin Vale, MD

Naval Daver

Oncologist discussing targets and mechanisms of action

MD Anderson Cancer Center

Episode: S16 Ep28: Medical Crossfire®: Menin Inhibitors in AML—Dissecting the Data to Define the Role

Host

Courtney Flaherty

Host of OncLive On Air

Reviews

4.5 out of 5 stars from 31 ratings

Best option for CME podcasts
Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!
Apple Podcasts
5
Dlshaka
United States9 months ago
My favorite podcast for oncology
This podcast provides excellent information to anyone who works in the medical field on oncology.
Apple Podcasts
5
Chiliman1986
United States6 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

The show is highly regarded for its focused content on oncology, which is seen as valuable for those in the medical field.

Listeners appreciate the wealth of information provided, particularly highlighting its relevance for continuing medical education and professional growth.

Top Health & Fitness Podcasts

The Dylan Gemelli PodcastDylan Gemelli

Huberman LabScicomm Media

Passion Struck with John R. MilesPassion Struck Network

Nothing much happens: bedtime stories to help you sleepWellness Loud

On Purpose with Jay ShettyiHeartPodcasts

We're Out of TimeRichard Taite

The Dr. John Delony ShowRamsey Network

Decoded | Unlock The Secrets of Human Behavior, Emotion and MotivationBizzie Gold | Mental Health Innovator and Break Method Founder

Get Sleepy: Sleep meditation and storiesSlumber Studios

The School of GreatnessLewis Howes

Talking Points

Recent interactions between the hosts and their guests.

S16 Ep35: T-DXd Trials Transform Treatment for HER2-Positive Breast Cancer: With Sara Nunnery, MD, MSCI; and Kelly E. McCann, MD, PhD

Q: How might these trials influence clinical practice and guidelines, particularly regarding neoadjuvant strategies and brain metastasis risk?

Results support a potential shift toward TDXd-containing regimens in neoadjuvant/adjuvant settings for high-risk patients, with careful attention to guideline inclusion, CNS protection considerations, and individualization of therapy based on patient risk and tolerability.

S16 Ep35: T-DXd Trials Transform Treatment for HER2-Positive Breast Cancer: With Sara Nunnery, MD, MSCI; and Kelly E. McCann, MD, PhD

Q: What are the key toxicities and monitoring considerations with TDXd, especially in the curative/adjuvant setting?

Main toxicities are GI symptoms and ILD; while grade 3 events were not higher overall in the TDXd arm, there were fatalities related to ILD, necessitating close monitoring, regular imaging, and careful patient selection and education.

S16 Ep35: T-DXd Trials Transform Treatment for HER2-Positive Breast Cancer: With Sara Nunnery, MD, MSCI; and Kelly E. McCann, MD, PhD

Q: How do the PASCR rates with TDXd compare to traditional chemotherapy in the overall population and by HR status?

TDXd improved PASCR rates overall by about 11 percentage points (67% vs 56%), with larger gains in HR-negative patients (83% in TDXd vs 67% control) and meaningful but smaller gains in HR-positive patients.

S16 Ep33: Real-World Data Support ctDNA-Guided Treatment Strategies in FGFR2-Altered Cholangiocarcinoma: With Marina Baretti, MD

Q: Really, what are some of the current limitations regarding the optimal clinical implementation of CT DNA test results in this disease?

The main limitations include non-standardized use outside research, variability in testing timing and frequency, inconsistent therapy data capture, and the lack of centralized radiologic review, all of which complicate translating ctDNA results into routine clinical decisions.

S16 Ep30: ASH Guidelines Provide Key Recommendations for AYA Acute Lymphoblastic Leukemia Management: With Wendy Stock, MD

Q: Within the AYA population, what is the current view on where allogeneic transplant might be appropriate and how high-risk features affect timing?

There is a general stance against proceeding to an allogeneic transplant in first remission due to limited randomized data, with caveats for high-risk biological subsets and the crucial role of MRD assessment in deciding whether to transplant.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

Focusing on the latest advancements in oncology, this show offers insights from academic oncologists on cutting-edge research and treatments. Discussions range across various cancer types, including lung, breast, gastrointestinal, hematologic, gynecologic, and genitourinary cancers, reflecting a comprehensive approach to modern cancer care. Unique to this program is its emphasis on both systemic therapies and innovative therapeutic methods, providing listeners with a deep understanding of emerging trends in oncology.

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncLive® On Air?

These podcasts share a similar audience with OncLive® On Air:

1. Oncology Brothers: Practice-Changing Cancer Discussions
2. Oncology Today with Dr Neil Love
3. Two Onc Docs
4. Research To Practice | Oncology Videos
5. ASCO Daily News

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 8 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. John Marshall
2. Christopher Lieu
3. Kelly McCann
4. Jae Park, MD
5. Marina Baretti
6. Neeta Somaiah
7. Wendy Stock, MD
8. Colin Vale

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days